Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity® Select Pharmaceuticals Portfolio (FPHAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.


1 month-6.42% 3 years+16.05%
3 months-9.66% 5 years+16.08%
1 year-6.75% Since inception+8.44%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+16.08%+21.20%
Expense ratio0.79%1.36%
Risk 5 year sharpe ratio1.341.12
Net assets$1.8B$3.4B
Average market cap$53.0B$36.5B
Average P/E23.722.4
Portfolio turnover72%72%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureAsher Anolic / 2 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00


U.S. stock66.61%
International stock33.42%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 98.48%
Hardware 0.61%
Consumer goods 0.39%
Business service 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson12.19%
AGN Allergan7.87%
SNY Sanofi6.91%
LLY Eli Lilly and Co5.61%
ABBV AbbVie5.42%
TEVA Teva Pharmaceutical4.95%
BMY Bristol-Myers Squibb4.93%
PFE Pfizer4.79%
NVO Novo Nordisk3.88%
GSK GlaxoSmithKline3.42%

Partner Offers